JP2008542205A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542205A5
JP2008542205A5 JP2008510309A JP2008510309A JP2008542205A5 JP 2008542205 A5 JP2008542205 A5 JP 2008542205A5 JP 2008510309 A JP2008510309 A JP 2008510309A JP 2008510309 A JP2008510309 A JP 2008510309A JP 2008542205 A5 JP2008542205 A5 JP 2008542205A5
Authority
JP
Japan
Prior art keywords
group
ether group
ether
compound represented
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008510309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542205A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/017706 external-priority patent/WO2006122020A2/en
Publication of JP2008542205A publication Critical patent/JP2008542205A/ja
Publication of JP2008542205A5 publication Critical patent/JP2008542205A5/ja
Pending legal-status Critical Current

Links

JP2008510309A 2005-05-06 2006-05-08 4−ビフェニリルアゼチジン−2−オンの製造方法 Pending JP2008542205A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67833605P 2005-05-06 2005-05-06
US72692905P 2005-10-14 2005-10-14
PCT/US2006/017706 WO2006122020A2 (en) 2005-05-06 2006-05-08 Process for production of 4-biphenylyazetidin-2-ones

Publications (2)

Publication Number Publication Date
JP2008542205A JP2008542205A (ja) 2008-11-27
JP2008542205A5 true JP2008542205A5 (https=) 2009-07-30

Family

ID=37101971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008510309A Pending JP2008542205A (ja) 2005-05-06 2006-05-08 4−ビフェニリルアゼチジン−2−オンの製造方法

Country Status (14)

Country Link
US (1) US20080287663A1 (https=)
EP (1) EP1893571A2 (https=)
JP (1) JP2008542205A (https=)
KR (1) KR20080011687A (https=)
AU (1) AU2006244212A1 (https=)
BR (1) BRPI0611045A2 (https=)
CA (1) CA2607939A1 (https=)
EA (1) EA200702428A1 (https=)
IL (1) IL187155A0 (https=)
MA (1) MA29496B1 (https=)
MX (1) MX2007013872A (https=)
NO (1) NO20076161L (https=)
TW (1) TW200726746A (https=)
WO (1) WO2006122020A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007014162A (es) * 2005-05-09 2008-04-04 Microbia Inc Agentes de acoplamiento de bencenfosfonatos organometalicos.
MX2007014172A (es) * 2005-05-11 2008-04-02 Microbia Inc Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
JP2008545700A (ja) * 2005-05-25 2008-12-18 マイクロビア インコーポレーテッド 4−(ビフェニリル)アゼチジン−2−オンホスホン酸類の製造方法
WO2008061238A2 (en) * 2006-11-16 2008-05-22 Ironwood Pharmaceuticals, Inc. Processes for production of 4-biphenylyazetidin-2-ones
CN101993403B (zh) * 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
WO2013152476A1 (en) 2012-04-10 2013-10-17 Theracos, Inc. Process for the preparation of benzylbenzene sglt2 inhibitors

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794734A (en) 1971-03-03 1974-02-26 Merck & Co Inc Methods of treating edema and hypertension using certain 2-aminoethylphenols
US5561227A (en) * 1991-07-23 1996-10-01 Schering Corporation Process for the stereospecific synthesis of azetidinones
US5688787A (en) * 1991-07-23 1997-11-18 Schering Corporation Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
JP2525125B2 (ja) * 1991-07-23 1996-08-14 シェリング・コーポレーション 血清コレステロ―ル低下薬として有用な置換β−ラクタム化合物およびそれらの製法
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
CA2158191A1 (en) * 1994-09-16 1996-03-17 Junji Yokoi Method for preventing settlement of aquatic fouling organisms
US5656624A (en) * 1994-12-21 1997-08-12 Schering Corporation 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
EP1137634B1 (en) * 1998-12-07 2005-06-15 Schering Corporation Process for the synthesis of azetidinones
PH12000002657B1 (en) * 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
IL156552A0 (en) 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
EP1345895B1 (de) * 2000-12-21 2006-12-27 Sanofi-Aventis Deutschland GmbH Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
DK1373230T3 (da) * 2001-03-28 2005-11-07 Schering Corp Enantiselektiv syntese af azetidinon mellemprodukter
TWI254635B (en) * 2002-08-05 2006-05-11 Yamanouchi Pharma Co Ltd Azulene derivative and salt thereof
EP1626954A2 (en) * 2003-05-05 2006-02-22 Ranbaxy Laboratories, Ltd. Process for the preparation of trans-isomers of diphenylazetidinone derivatives
ATE369335T1 (de) * 2003-11-10 2007-08-15 Microbia Inc 4-biarylyl-1-phenylazetidin-2-one
MX2007014172A (es) * 2005-05-11 2008-04-02 Microbia Inc Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.

Similar Documents

Publication Publication Date Title
JP2008540557A5 (https=)
JP2008545700A5 (https=)
EP1840125B1 (fr) Intermédiaires pour la production de dioxane-2-alkylcarbamates
JP2011500769A5 (https=)
JP2007511546A5 (https=)
JP2003520235A5 (https=)
CA2472776A1 (en) Process for the manufacture of hmg-coa reductase inhibitors
JP2006509046A5 (https=)
JP2008542205A5 (https=)
JP2004083852A5 (https=)
WO2004087790A3 (de) Gemische von (meth)acrylester von polyalkoxyliertem trimethylolpropan
JP6222973B2 (ja) ジベンジルトリチオカーボネート誘導体
JP2011513358A5 (https=)
JP2006512470A5 (https=)
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
US7335785B2 (en) Acetylene alcohols having a fluoroalkyl group and methods for preparing the same
JP2010510185A5 (https=)
DE602004002117T2 (de) Verfahren zur Herstellung eines Alkoxysilans
JP2007513070A5 (https=)
JP4651969B2 (ja) エポキシトリアゾール化合物の製造方法
DK2336114T3 (da) Fremgangsmåde til syntese af l-3,4 dihydroxy-6-[18f]fluor-phenylalanin og 2-[18f]fluor-l-tyrosin og deres alfa-methylerede derivater startende fra en precursor
JP6262972B2 (ja) 化合物、及びその製造方法、並びにボリコナゾールの製造方法
Kvíčala et al. Preparation of Intermediates for Fluorinated Lignans by Conjugated and Tandem Additions on 3-Fluorofuran-2 (5H)-one
JP2007503406A5 (https=)
JP2007246517A (ja) 光学活性な5−ヒドロキシ−3−ケトエステル化合物の製法